Thanks, your correction saved me a post.
If all non-biopsied positives are automatically reported as false positives, the specificity is lowered artificially. So really these ones should be ignored when calculating specificity
I agree that the CU6 announcement didn't explain this "problem" well, or even at all.
Research/Valuation, page-195
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.93 |
Change
-0.030(0.76%) |
Mkt cap ! $1.224B | |||
| Open | High | Low | Value | Volume |
| $3.97 | $4.12 | $3.81 | $5.484M | 1.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7422 | $3.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.95 | 4277 | 7 |
View Market Depth
| Last trade - 13.58pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.96 |
Change
-0.030 ( 0.60 %) |
||||
| Open | High | Low | Volume | ||
| $4.00 | $4.13 | $3.81 | 70050 | ||
| Last updated 14.11pm 10/05/2024 ? | |||||
| CU6 (ASX) Chart |